dichloroacetic acid has been researched along with nutlin-3a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Agnoletto, C; Brunelli, L; Casciano, F; Celeghini, C; Cuneo, A; Melloni, E; Rigolin, GM; Rimondi, E; Secchiero, P; Zauli, G | 1 |
Danker, K; Eickholt, B; Klein, A; Parczyk, J; Ruhnau, J | 1 |
2 other study(ies) available for dichloroacetic acid and nutlin-3a
Article | Year |
---|---|
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3.
Topics: Aged; Aged, 80 and over; Dichloroacetic Acid; Drug Synergism; Female; Humans; Imidazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperazines; Tumor Suppressor Protein p53 | 2014 |
Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Dichloroacetic Acid; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; L-Lactate Dehydrogenase; Mustard Compounds; Phenylpropionates; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyruvate Dehydrogenase Complex; Reproducibility of Results | 2020 |